关注
Salvador Alejo PhD
Salvador Alejo PhD
MD/PhD Student; University of Texas Health San Antonio
在 livemail.uthscsa.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase
F Leng, J Yu, C Zhang, S Alejo, N Hoang, H Sun, F Lu, H Zhang
Nature communications 9 (1), 1641, 2018
542018
Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4DCAF5 ubiquitin ligase
C Zhang, F Leng, L Saxena, N Hoang, J Yu, S Alejo, L Lee, D Qi, F Lu, ...
Journal Of Biological Chemistry 294 (2), 476-489, 2019
432019
LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase–dependent proteolysis of the stem-cell protein SOX2
C Zhang, N Hoang, F Leng, L Saxena, L Lee, S Alejo, D Qi, A Khal, H Sun, ...
Journal Of Biological Chemistry 293 (10), 3663-3674, 2018
352018
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
M Zhou, PP Venkata, S Viswanadhapalli, B Palacios, S Alejo, Y Chen, ...
Breast cancer research and treatment 185, 343-357, 2021
312021
HGF-induced formation of the MET–AXL–ELMO2–DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion
W Li, X Xiong, A Abdalla, S Alejo, L Zhu, F Lu, H Sun
Journal of Biological Chemistry 293 (40), 15397-15418, 2018
272018
Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair
M Wang, W Li, N Tomimatsu, HY Corey, JH Ji, S Alejo, SR Witus, ...
Molecular cell 83 (20), 3679-3691. e8, 2023
142023
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer
PP Venkata, Y Chen, S Alejo, Y He, BE Palacios, I Loeffel, J Liu, ...
Cancer letters 524, 219-231, 2022
142022
Therapeutic targeting of ovarian cancer stem cells using estrogen receptor beta agonist
Y He, S Alejo, PP Venkata, JD Johnson, I Loeffel, UP Pratap, Y Zou, Z Lai, ...
International journal of molecular sciences 23 (13), 7159, 2022
132022
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells
GR Sareddy, UP Pratap, PP Venkata, M Zhou, S Alejo, S Viswanadhapalli, ...
Stem Cells 39 (5), 536-550, 2021
132021
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma
S Alejo, BE Palacios, PP Venkata, Y He, W Li, JD Johnson, Y Chen, ...
Neuro-oncology 25 (7), 1249-1261, 2023
112023
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
PP Venkata, S Jayamohan, Y He, S Alejo, JD Johnson, BE Palacios, ...
Cancer Letters 575, 216383, 2023
72023
Lysine-specific demethylase 1 as a therapeutic cancer target: Observations from preclinical study
JD Johnson, S Alejo, S Jayamohan, GR Sareddy
Expert opinion on therapeutic targets 27 (12), 1177-1188, 2023
52023
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer
Y Chen, JD Johnson, S Jayamohan, Y He, PP Venkata, D Jamwal, ...
Molecular Carcinogenesis 63 (10), 2026-2039, 2024
2024
DSS1 restrains BRCA2’s engagement with dsDNA for homologous recombination, replication fork protection, and R-loop homeostasis
Y Huang, W Li, T Foo, JH Ji, B Wu, N Tomimatsu, Q Fang, B Gao, M Long, ...
Nature Communications 15 (1), 7081, 2024
2024
Abstract PO4-28-08: Unraveling the Role of BRCA1-BARD1 E3 Ubiquitin Ligase in DNA Repair: A Promise for Enhanced Chemotherapy Outcomes
W Li, M Wang, N Tomimatsu, JH Ji, S Alejo, GR Sareddy, S Burma, ...
Cancer Research 84 (9_Supplement), PO4-28-08-PO4-28-08, 2024
2024
PELP1 inhibition enhances the therapeutic efficacy of topoisomerase inhibitors in triple-negative breast cancer
KM Nassar, JR Sanchez, DM Panneerdoss, B Ebrahimi, Y Xue, UP Pratap, ...
Cancer Research 84 (6_Supplement), 2099-2099, 2024
2024
KDM1A/LSD1 inhibition enhances estrogen receptor beta mediated tumor suppression in ovarian cancer
PP Venkata, S Jayamohan, Y He, S Alejo, JD Johnson, UP Pratap, ...
Cancer Research 83 (7_Supplement), 3081-3081, 2023
2023
301 Inhibition of lysine-specific histone demethylase 1A (KDM1A/LSD1) attenuates DNA double strand break repair and enhances efficacy of temozolomide in glioblastoma
S Alejo, B Palacios, PP Venkata, Y He, W Li, J Johnson, S Jayamohan, ...
Journal of Clinical and Translational Science 7 (s1), 90-90, 2023
2023
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression
Y He, S Alejo, JD Johnson, S Jayamohan, GR Sareddy
Cancers 15 (7), 2008, 2023
2023
KDM1A inhibition augment ER stress inducers efficacy to reduce glioblastoma stemness
Y He, PP Venkata, S Alejo, Y Chen, B Palacios, G Gray, UP Pratap, ...
Cancer Research 81 (13_Supplement), 2026-2026, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20